comparemela.com
Home
Live Updates
Clinical Development At Biomarin - Breaking News
Pages:
Latest Breaking News On - Clinical development at biomarin - Page 1 : comparemela.com
Alpine Immune Sciences Announces Appointment of Wolfgang Dummer, M D , Ph D , as Chief Medical Officer and Grant under Nasdaq Listing Rule 5635(c)
SEATTLE (BUSINESS WIRE) Oct 4, 2023
United states
Temre johnson
Wolfgang dummer
Andrew sandler
Technical university of munich
Clinical development at biomarin
Securities exchange
Alpine immune sciences inc
Global development leader
Alpine immune sciences
Rigel pharmaceuticals
Exchange commission
Immune sciences
Chief medical officer
Executive chairman
Chief executive
vimarsana © 2020. All Rights Reserved.